Literature DB >> 3130056

Adenosine inhibits phenylephrine activation of phospholipase A in hamster brown adipocytes.

R J Schimmel1, M E Elliott.   

Abstract

Exposure of brown adipocytes to phenylephrine activates a phospholipase A2 producing arachidonic acid and lysophospholipids. When adipocytes were incubated with adenosine deaminase, a greater release of arachidonic acid and accumulation of lysophosphatidyl-choline in response to phenylephrine was noted. The potentiating effect of adenosine deaminase was also observed in the presence of A23187 and for both stimuli, the effect of adenosine deaminase was reversed by phenylisopropyladenosine. These results suggest the presence of an heretofore unrecognized action of adenosine, namely inhibition of phospholipase A2 activity in brown fat cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130056     DOI: 10.1016/s0006-291x(88)80122-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Changes in phosphoinositide-specific phospholipase C and phospholipase A2 activity in ischemic and reperfused rat heart.

Authors:  D W Schwertz; J Halverson
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

2.  Purine nucleotides modulate proliferation of brown fat preadipocytes.

Authors:  S M Wilson; M J Barsoum; B W Wilson; P A Pappone
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

3.  Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.

Authors:  Octavia Cadassou; Muhammad-Zawwad Raza; Christelle Machon; Laura Gudefin; Célia Armanet; Kamel Chettab; Jérôme Guitton; Maria Grazia Tozzi; Charles Dumontet; Emeline Cros-Perrial; Lars Petter Jordheim
Journal:  Cell Oncol (Dordr)       Date:  2020-09-24       Impact factor: 6.730

4.  Adenosine A1-receptor stimulated increases in intracellular calcium in the smooth muscle cell line, DDT1MF-2.

Authors:  J M Dickenson; S J Hill
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.